𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt

✍ Scribed by F D Gordon; H T Anastopoulos; W Crenshaw; B Gilchrist; N McEniff; K R Falchuk; J LoCicero; W D Lewis; R L Jenkins; C Trey

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
225 KB
Volume
25
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Transjugular intrahepatic portosystemic
Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax
✍ Jeffries, Mark A. ;Kazanjian, Sahira ;Wilson, Mark ;Punch, Jeffrey ;Fontana, Rob πŸ“‚ Article πŸ“… 1998 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 69 KB

Hepatic hydrothorax is a relatively infrequent but potentially serious complication of cirrhosis resulting from the accumulation of ascitic fluid in the chest cavity. Medical management is initially directed at controlling ascites formation, but invasive therapeutic procedures may be required if sym

Incarceration of umbilical hernia follow
Incarceration of umbilical hernia following transjugular intrahepatic portosystemic shunt for the treatment of ascites
✍ Trotter, James F. ;Suhocki, Paul V. πŸ“‚ Article πŸ“… 1999 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 37 KB

Transjugular intrahepatic portosystemic shunt (TIPS) is an effective therapy for patients with medically refractory ascites. Many patients with refractory ascites have umbilical herniation. Incarceration of umbilical hernia has been reported following diuresis, paracentesis, and peritoneove-nous shu

Transjugular intrahepatic portosystemic
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis
✍ George V. Papatheodoridis; John Goulis; Gioacchino Leandro; David Patch; Andrew πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 136 KB πŸ‘ 2 views

Endoscopic treatment (ET) is frequently used to prevent variceal rebleeding but this still occurs in about 50% of patients. Recently, transjugular intrahepatic portosystemic shunt (TIPS) has been compared with ET in several trials. Using a meta-analysis, we evaluated randomized trials comparing TIPS

Renal effects of transjugular intrahepat
Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: Comparison of patients with ascites, with refractory ascites, or without ascites
✍ Alexander L. Gerbes; Veit GΓΌlberg; Tobias Waggershauser; Josef Holl; Maximilian πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 119 KB πŸ‘ 2 views

Renal effects of the transjugular intrahepatic portosystemic shunt (TIPS) were compared in 6 patients without ascites (group 1), 11 patients with ascites responding to diuretic treatment (group 2), and 6 patients with refractory ascites (group 3). Seven days after insertion of TIPS, 24-hour urinary

Transjugular intrahepatic portosystemic
Transjugular intrahepatic portosystemic shunt for treatment of intractable colonic ischemia associated with portal hypertension: A bridge to liver transplantation
✍ Jonathan A. Schneider; Edward A. White; Derek C. Welch; LeAnn S. Stokes; David S πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 200 KB

A 64-year-old man with portal hypertension secondary to hepatic nodular transformation was awaiting liver transplantation when he presented with severe, unrelenting abdominal pain, fever, and hypotension. Computed tomographyrevealed pneumatosis within the cecum and ascending colon. Because of his ad